• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For May 15, 2023

    5/15/23 5:32:35 AM ET
    $PEV
    $PHGE
    $POAI
    $POCI
    Construction/Ag Equipment/Trucks
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $PEV alert in real time by email

    Companies Reporting Before The Bell

    • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter.

    • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.

    • Modiv (NYSE:MDV) is estimated to report earnings for its first quarter.

    • LM Funding America (NASDAQ:LMFA) is estimated to report quarterly loss at $0.48 per share on revenue of $1.40 million.

    • Sachem Cap (AMEX:SACH) is projected to report quarterly earnings at $0.13 per share on revenue of $14.72 million.

    • Lifeway Foods (NASDAQ:LWAY) is likely to report quarterly earnings at $0.08 per share on revenue of $36.00 million.

    • iSun (NASDAQ:ISUN) is expected to report quarterly loss at $0.20 per share on revenue of $19.78 million.

    • Carlyle Group (NASDAQ:CG) is likely to report quarterly loss at $0.09 per share on revenue of $221.89 million.

    • Azul (NYSE:AZUL) is projected to report quarterly loss at $0.34 per share on revenue of $932.13 million.

    • Brainstorm Cell (NASDAQ:BCLI) is projected to report earnings for its first quarter.

    • Costamare (NYSE:CMRE) is estimated to report quarterly earnings at $0.46 per share on revenue of $229.12 million.

    • Data Storage (NASDAQ:DTST) is estimated to report quarterly earnings at $0.02 per share on revenue of $6.40 million.

    • Catalent (NYSE:CTLT) is expected to report quarterly earnings at $0.43 per share on revenue of $1.03 billion.

    • Li-Cycle Holdings (NYSE:LICY) is likely to report quarterly loss at $0.16 per share on revenue of $6.33 million.

    • Terran Orbital (NYSE:LLAP) is estimated to report quarterly loss at $0.19 per share on revenue of $30.95 million.

    • Bitfarms (NASDAQ:BITF) is likely to report quarterly loss at $0.04 per share on revenue of $34.79 million.

    • SNDL (NASDAQ:SNDL) is expected to report earnings for its first quarter.

    • Trevena (NASDAQ:TRVN) is likely to report quarterly loss at $0.98 per share on revenue of $230 thousand.

    • SPAR Group (NASDAQ:SGRP) is expected to report earnings for its first quarter.

    • SuperCom (NASDAQ:SPCB) is expected to report quarterly loss at $0.51 per share on revenue of $4.50 million.

    • Edible Garden AG (NASDAQ:EDBL) is expected to report quarterly loss at $1.22 per share on revenue of $2.16 million.

    • EuroDry (NASDAQ:EDRY) is estimated to report quarterly loss at $0.28 per share on revenue of $14.50 million.

    • LENSAR (NASDAQ:LNSR) is expected to report quarterly loss at $0.27 per share on revenue of $9.10 million.

    • First American Financial (NYSE:FAF) is expected to report quarterly loss at $0.18 per share on revenue of $46.65 million.

    • IM Cannabis (NASDAQ:IMCC) is likely to report quarterly loss at $0.28 per share on revenue of $13.80 million.

    • Ondas Holdings (NASDAQ:ONDS) is estimated to report quarterly loss at $0.28 per share on revenue of $1.63 million.

    • Minerva Neurosciences (NASDAQ:NERV) is projected to report earnings for its first quarter.

    • FREYR Battery (NYSE:FREY) is likely to report quarterly loss at $0.29 per share on revenue of $2.08 million.

    • Nogin (NASDAQ:NOGN) is likely to report quarterly loss at $1.16 per share on revenue of $20.28 million.

    • Altisource Asset Mgmt (AMEX:AAMC) is likely to report earnings for its first quarter.

    • Moving iMage Technologies (AMEX:MITQ) is expected to report earnings for its third quarter.

    • InspireMD (NASDAQ:NSPR) is estimated to report quarterly loss at $0.68 per share on revenue of $1.00 million.

    • Genius Gr (AMEX:GNS) is projected to report earnings for its fourth quarter.

    • Fulcrum Therapeutics (NASDAQ:FULC) is likely to report quarterly loss at $0.46 per share on revenue of $1.13 million.

    • SPDR Select Sector Fund - Consumer Discretionary (NYSE:XLY) is expected to report quarterly loss at $0.01 per share on revenue of $25.40 million.

    • Where Food Comes From (NASDAQ:WFCF) is likely to report earnings for its first quarter.

    • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.11 per share on revenue of $10.90 million.

    • Novan (NASDAQ:NOVN) is likely to report quarterly loss at $0.32 per share on revenue of $6.38 million.

    • Advent Technologies Hldgs (NASDAQ:ADN) is estimated to report earnings for its first quarter.

    • Jaguar Health (NASDAQ:JAGX) is expected to report earnings for its first quarter.

    • Alimera Sciences (NASDAQ:ALIM) is projected to report quarterly loss at $0.51 per share on revenue of $12.30 million.

    • Mitsubishi UFJ Finl Gr (NYSE:MUFG) is projected to report earnings for its fourth quarter.

    • BiomX (AMEX:PHGE) is projected to report earnings for its first quarter.

    • Twin Vee PowerCats (NASDAQ:VEEE) is estimated to report earnings for its first quarter.

    • DecisionPoint Sys (AMEX:DPSI) is projected to report quarterly earnings at $0.06 per share on revenue of $19.00 million.

    • Tingo Group (NASDAQ:TIO) is projected to report quarterly earnings at $0.28 per share on revenue of $385.00 million.

    • Mondee Hldgs (NASDAQ:MOND) is estimated to report quarterly loss at $0.12 per share on revenue of $43.88 million.

    • Vislink Technologies (NASDAQ:VISL) is projected to report quarterly loss at $0.80 per share on revenue of $7.44 million.

    • Prestige Consumer (NYSE:PBH) is estimated to report quarterly earnings at $0.76 per share on revenue of $1.38 billion.

    • Compugen (NASDAQ:CGEN) is projected to report earnings for its first quarter.

    • Star Equity Hldgs (NASDAQ:STRR) is likely to report quarterly earnings at $0.00 per share on revenue of $27.00 million.

    • Harbor Custom Dev (NASDAQ:HCDI) is expected to report quarterly loss at $5.46 per share on revenue of $11.90 million.

    • PDS Biotechnology (NASDAQ:PDSB) is likely to report earnings for its first quarter.

    • Movano (NASDAQ:MOVE) is likely to report earnings for its first quarter.

    • LanzaTech Global (NASDAQ:LNZA) is estimated to report earnings for its first quarter.

    • Fathom Digital Mfg (NYSE:FATH) is expected to report quarterly loss at $0.05 per share on revenue of $32.60 million.

    • Altus Power (NYSE:AMPS) is expected to report quarterly loss at $0.04 per share on revenue of $30.17 million.

    • Tower Semiconductor (NASDAQ:TSEM) is likely to report quarterly earnings at $0.47 per share on revenue of $352.35 million.

    • Venus Concept (NASDAQ:VERO) is projected to report quarterly loss at $0.14 per share on revenue of $18.58 million.

    • Gracell Biotechnologies (NASDAQ:GRCL) is estimated to report earnings for its first quarter.

    • Rockwell Medical (NASDAQ:RMTI) is projected to report quarterly loss at $0.16 per share on revenue of $19.12 million.

    • Monday.Com (NASDAQ:MNDY) is estimated to report quarterly loss at $0.28 per share on revenue of $155.33 million.

    • Science 37 Hldgs (NASDAQ:SNCE) is likely to report quarterly loss at $0.13 per share on revenue of $12.88 million.

    • TPG (NASDAQ:TPG) is projected to report quarterly earnings at $0.33 per share on revenue of $296.50 million.

    • Centerra Gold (NYSE:CGAU) is expected to report earnings for its first quarter.

    • Central Puerto (NYSE:CEPU) is likely to report earnings for its first quarter.

    Companies Reporting After The Bell

    • Sunlight Finl Hldgs (NYSE:SUNL) is projected to report quarterly loss at $0.06 per share on revenue of $17.08 million.

    • Pyxis Tankers (NASDAQ:PXS) is estimated to report earnings for its first quarter.

    • FG Group Holdings (AMEX:FGH) is estimated to report earnings for its first quarter.

    • Gamida Cell (NASDAQ:GMDA) is projected to report earnings for its first quarter.

    • Inpixon (NASDAQ:INPX) is estimated to report earnings for its first quarter.

    • KULR Tech Gr (AMEX:KULR) is expected to report quarterly loss at $0.04 per share on revenue of $2.22 million.

    • GEE Group (AMEX:JOB) is likely to report earnings for its second quarter.

    • Enthusiast Gaming Hldgs (NASDAQ:EGLX) is estimated to report quarterly loss at $0.07 per share on revenue of $33.34 million.

    • Absolute Software (NASDAQ:ABST) is estimated to report quarterly loss at $0.10 per share on revenue of $79.64 million.

    • XP (NASDAQ:XP) is projected to report quarterly earnings at $0.28 per share on revenue of $621.76 million.

    • Tivic Health Systems (NASDAQ:TIVC) is projected to report quarterly loss at $0.11 per share on revenue of $520 thousand.

    • Park City Gr (NASDAQ:PCYG) is expected to report quarterly earnings at $0.07 per share on revenue of $4.77 million.

    • Rumble (NASDAQ:RUM) is likely to report quarterly loss at $0.01 per share on revenue of $15.93 million.

    • Strata Skin Sciences (NASDAQ:SSKN) is estimated to report quarterly loss at $0.07 per share on revenue of $9.78 million.

    • Stryve Foods (NASDAQ:SNAX) is estimated to report quarterly loss at $0.16 per share on revenue of $4.70 million.

    • XWELL (NASDAQ:XWEL) is likely to report quarterly loss at $0.13 per share on revenue of $7.38 million.

    • Beam Glb (NASDAQ:BEEM) is likely to report quarterly loss at $0.42 per share on revenue of $8.28 million.

    • Spark Networks (NASDAQ:LOV) is likely to report earnings for its first quarter.

    • Greenbrook TMS (NASDAQ:GBNH) is projected to report quarterly loss at $0.36 per share on revenue of $18.92 million.

    • Phoenix Motor (NASDAQ:PEV) is expected to report earnings for its first quarter.

    • Upexi (NASDAQ:UPXI) is estimated to report earnings for its third quarter.

    • FaZe Hldgs (NASDAQ:FAZE) is likely to report earnings for its first quarter.

    • NexGel (NASDAQ:NXGL) is expected to report earnings for its first quarter.

    • Consolidated Water Co (NASDAQ:CWCO) is projected to report quarterly earnings at $0.19 per share on revenue of $28.25 million.

    • cbdMD (AMEX:YCBD) is estimated to report earnings for its second quarter.

    • Dolphin Entertainment (NASDAQ:DLPN) is likely to report quarterly loss at $0.09 per share on revenue of $9.70 million.

    • ThermoGenesis Holdings (NASDAQ:THMO) is expected to report quarterly loss at $0.31 per share on revenue of $2.80 million.

    • CymaBay Therapeutics (NASDAQ:CBAY) is projected to report quarterly loss at $0.09 per share on revenue of $21.35 million.

    • BIO-key Intl (NASDAQ:BKYI) is estimated to report quarterly loss at $0.27 per share on revenue of $2.00 million.

    • Celcuity (NASDAQ:CELC) is likely to report earnings for its first quarter.

    • Sigma Additive Solutions (NASDAQ:SASI) is expected to report quarterly loss at $0.18 per share on revenue of $310 thousand.

    • Cormedix (NASDAQ:CRMD) is estimated to report earnings for its first quarter.

    • Inhibikase Therapeutics (NASDAQ:IKT) is expected to report earnings for its first quarter.

    • Crown ElectroKinetics (NASDAQ:CRKN) is likely to report earnings for its first quarter.

    • Super League Gaming (NASDAQ:SLGG) is projected to report quarterly loss at $0.21 per share on revenue of $4.49 million.

    • TOMI Environmental Solns (NASDAQ:TOMZ) is estimated to report quarterly loss at $0.02 per share on revenue of $2.90 million.

    • OMNIQ (NASDAQ:OMQS) is projected to report quarterly loss at $0.32 per share on revenue of $27.70 million.

    • Precision Optics Corp (NASDAQ:POCI) is expected to report earnings for its third quarter.

    • Zevra Therapeutics (NASDAQ:ZVRA) is likely to report quarterly loss at $0.23 per share on revenue of $2.65 million.

    • Chicken Soup for the Soul (NASDAQ:CSSE) is estimated to report quarterly loss at $1.69 per share on revenue of $110.66 million.

    • Greenlane Hldgs (NASDAQ:GNLN) is likely to report quarterly loss at $1.18 per share on revenue of $23.95 million.

    • Lucid Diagnostics (NASDAQ:LUCD) is estimated to report quarterly loss at $0.35 per share on revenue of $220 thousand.

    • Hall Of Fame Resort (NASDAQ:HOFV) is expected to report quarterly loss at $2.27 per share on revenue of $3.58 million.

    • INVO Bioscience (NASDAQ:INVO) is estimated to report earnings for its first quarter.

    • Intellinetics (AMEX:INLX) is expected to report quarterly earnings at $0.02 per share on revenue of $3.95 million.

    • Adamis Pharmaceuticals (NASDAQ:ADMP) is likely to report earnings for its first quarter.

    • CVD Equipment (NASDAQ:CVV) is estimated to report earnings for its first quarter.

    • Digital Media Solns (NYSE:DMS) is expected to report quarterly loss at $0.13 per share on revenue of $90.66 million.

    • Know Labs (AMEX:KNW) is estimated to report earnings for its second quarter.

    • Biora Therapeutics (NASDAQ:BIOR) is expected to report earnings for its first quarter.

    • GSE Systems (NASDAQ:GVP) is estimated to report quarterly loss at $0.07 per share on revenue of $12.68 million.

    • DiaMedica Therapeutics (NASDAQ:DMAC) is expected to report earnings for its first quarter.

    • Onconova Therapeutics (NASDAQ:ONTX) is estimated to report quarterly loss at $0.30 per share on revenue of $90 thousand.

    • BRF (NYSE:BRFS) is expected to report quarterly loss at $0.09 per share on revenue of $2.59 billion.

    • Vicinity Motor (NASDAQ:VEV) is projected to report earnings for its first quarter.

    • American Res (NASDAQ:AREC) is expected to report quarterly loss at $0.06 per share on revenue of $10.20 million.

    • VOXX International (NASDAQ:VOXX) is expected to report quarterly loss at $0.04 per share on revenue of $125.38 million.

    • Predictive Oncology (NASDAQ:POAI) is likely to report earnings for its first quarter.

    • Yalla Group (NYSE:YALA) is likely to report earnings for its first quarter.

    • OpGen (NASDAQ:OPGN) is expected to report quarterly loss at $1.20 per share on revenue of $1.60 million.

    • Arrival (NASDAQ:ARVL) is estimated to report earnings for its first quarter.

    • SHF Hldgs (NASDAQ:SHFS) is estimated to report earnings for its first quarter.

    • Trxade Health (NASDAQ:MEDS) is expected to report quarterly loss at $0.04 per share on revenue of $2.66 million.

    • Midwest Holding (NASDAQ:MDWT) is projected to report quarterly loss at $0.03 per share on revenue of $15.70 million.

    • P10 (NYSE:PX) is estimated to report quarterly earnings at $0.19 per share on revenue of $55.22 million.

    • Shapeways Holdings (NYSE:SHPW) is estimated to report quarterly loss at $0.13 per share on revenue of $7.80 million.

    • Presto Automation (NASDAQ:PRST) is likely to report quarterly loss at $0.21 per share on revenue of $7.40 million.

    • Grindr (NYSE:GRND) is likely to report earnings for its first quarter.

    • Fortuna Silver Mines (NYSE:FSM) is projected to report quarterly earnings at $0.01 per share on revenue of $160.60 million.

    • Investcorp Credit (NASDAQ:ICMB) is estimated to report quarterly earnings at $0.16 per share on revenue of $6.62 million.

    • Glimpse Group (NASDAQ:VRAR) is estimated to report earnings for its third quarter.

    • Mineralys Therapeutics (NASDAQ:MLYS) is estimated to report earnings for its first quarter.

    • Rekor Systems (NASDAQ:REKR) is expected to report quarterly loss at $0.20 per share on revenue of $6.28 million.

    • iPower (NASDAQ:IPW) is likely to report quarterly loss at $0.06 per share on revenue of $19.22 million.

    • Exagen (NASDAQ:XGN) is likely to report quarterly loss at $0.56 per share on revenue of $9.40 million.

    • James Hardie Industries (NYSE:JHX) is estimated to report earnings for its fourth quarter.

    • Quest Resource Holding (NASDAQ:QRHC) is expected to report quarterly loss at $0.08 per share on revenue of $71.57 million.

    • Pioneer Power Solutions (NASDAQ:PPSI) is estimated to report quarterly loss at $0.03 per share on revenue of $9.30 million.

    • ENDRA Life Sciences (NASDAQ:NDRA) is expected to report earnings for its first quarter.

    • Sanara MedTech (NASDAQ:SMTI) is likely to report quarterly loss at $0.33 per share on revenue of $16.20 million.

    • IZEA Worldwide (NASDAQ:IZEA) is estimated to report quarterly loss at $0.02 per share on revenue of $8.00 million.

    • Duos Technologies Group (NASDAQ:DUOT) is likely to report quarterly loss at $0.29 per share on revenue of $2.45 million.

    • Nauticus Robotics (NASDAQ:KITT) is likely to report quarterly loss at $0.16 per share on revenue of $2.40 million.

    • Navitas Semiconductor (NASDAQ:NVTS) is expected to report quarterly loss at $0.08 per share on revenue of $12.30 million.

    • CEA Industries (NASDAQ:CEAD) is likely to report earnings for its first quarter.

    • icad (NASDAQ:ICAD) is likely to report quarterly loss at $0.11 per share on revenue of $6.21 million.

    • Dragonfly Energy Hldgs (NASDAQ:DFLI) is estimated to report quarterly loss at $0.23 per share on revenue of $18.35 million.

    • Peraso (NASDAQ:PRSO) is likely to report quarterly loss at $0.10 per share on revenue of $4.52 million.

    • Addvantage Technologies (NASDAQ:AEY) is expected to report earnings for its first quarter.

    • Fluent (NASDAQ:FLNT) is expected to report quarterly loss at $0.01 per share on revenue of $81.50 million.

    • VirTra (NASDAQ:VTSI) is estimated to report quarterly earnings at $0.04 per share on revenue of $6.85 million.

    • Southland Holdings (AMEX:SLND) is projected to report quarterly loss at $0.04 per share on revenue of $237.45 million.

    • Danaos (NYSE:DAC) is estimated to report quarterly earnings at $5.89 per share on revenue of $209.71 million.

    • United Insurance Holdings (NASDAQ:UIHC) is estimated to report earnings for its first quarter.

    • T2 Biosystems (NASDAQ:TTOO) is projected to report quarterly loss at $1.20 per share on revenue of $2.33 million.

    • Spruce Power Holding (NYSE:SPRU) is estimated to report earnings for its first quarter.

    • Near Intelligence (NASDAQ:NIR) is likely to report earnings for its first quarter.

    • Cara Therapeutics (NASDAQ:CARA) is expected to report quarterly loss at $0.52 per share on revenue of $4.98 million.

    • Astra Space (NASDAQ:ASTR) is likely to report earnings for its first quarter.

    • Nu Holdings (NYSE:NU) is estimated to report quarterly earnings at $0.02 per share on revenue of $1.54 billion.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $PEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PEV
    $PHGE
    $POAI
    $POCI

    CompanyDatePrice TargetRatingAnalyst
    James Hardie Industries plc.
    $JHX
    2/11/2026Neutral → Overweight
    Analyst
    monday.com Ltd.
    $MNDY
    2/10/2026$80.00Buy → Hold
    Loop Capital
    monday.com Ltd.
    $MNDY
    2/10/2026$90.00Outperform → Neutral
    Robert W. Baird
    TPG Inc.
    $TPG
    2/9/2026$75.00Mkt Perform → Mkt Outperform
    Citizens
    Modiv Industrial Inc.
    $MDV
    2/4/2026$18.00Overweight
    Cantor Fitzgerald
    InspireMD Inc.
    $NSPR
    2/2/2026$6.00Buy
    Maxim Group
    TPG Inc.
    $TPG
    1/28/2026$78.00Overweight
    Barclays
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $PEV
    $PHGE
    $POAI
    $POCI
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.

    SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)

    2/11/26 7:24:32 PM ET
    $PHGE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Ondas Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Ondas Inc. (0001646188) (Filer)

    2/11/26 5:29:31 PM ET
    $ONDS
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Strata Skin Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events

    8-K - STRATA Skin Sciences, Inc. (0001051514) (Filer)

    2/11/26 5:00:57 PM ET
    $SSKN
    Medical/Dental Instruments
    Health Care

    $PEV
    $PHGE
    $POAI
    $POCI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    James Hardie upgraded by Analyst

    Analyst upgraded James Hardie from Neutral to Overweight

    2/11/26 7:25:30 AM ET
    $JHX
    Building Materials
    Industrials

    Monday.com downgraded by Loop Capital with a new price target

    Loop Capital downgraded Monday.com from Buy to Hold and set a new price target of $80.00

    2/10/26 8:00:13 AM ET
    $MNDY
    Computer Software: Prepackaged Software
    Technology

    Monday.com downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Monday.com from Outperform to Neutral and set a new price target of $90.00

    2/10/26 8:00:13 AM ET
    $MNDY
    Computer Software: Prepackaged Software
    Technology

    $PEV
    $PHGE
    $POAI
    $POCI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,920 worth of shares (3,000 units at $1.64), increasing direct ownership by 0.69% to 434,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/11/26 4:38:15 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Large owner Tether Global Investments Fund, S.I.C.A.F., S.A. bought $4,220,298 worth of shares (777,012 units at $5.43) (SEC Form 4)

    4 - Rumble Inc. (0001830081) (Issuer)

    2/6/26 8:42:27 PM ET
    $RUM
    Computer Software: Programming Data Processing
    Technology

    Chief Executive Officer O'Dowd William Iv bought $4,872 worth of shares (2,900 units at $1.68), increasing direct ownership by 0.68% to 431,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/2/26 5:25:10 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $PEV
    $PHGE
    $POAI
    $POCI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIVDELZI issued to CYMABAY THERAPEUTICS INC

    Submission status for CYMABAY THERAPEUTICS INC's drug LIVDELZI (ORIG-1) with active ingredient SELADELPAR has changed to 'Approval' on 08/14/2024. Application Category: NDA, Application Number: 217899, Application Classification: Type 1 - New Molecular Entity

    8/14/24 12:53:53 PM ET
    $CBAY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 17, 2023 - FDA Roundup: November 17, 2023

    For Immediate Release: November 17, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, to mark the 15th anniversary of the FDA foreign offices, the FDA published an interview with Susan Winckler, who was FDA chief of staff when the first office was opened in Beijing on November 19, 2008. Winckler is now CEO of the Reagan-Udall Foundation

    11/17/23 4:18:44 PM ET
    $BMY
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DEFENCATH issued to CORMEDIX INC

    Submission status for CORMEDIX INC's drug DEFENCATH (ORIG-1) with active ingredient TAUROLIDINE AND HEPARIN SODIUM has changed to 'Approval' on 11/15/2023. Application Category: NDA, Application Number: 214520, Application Classification: Type 1 - New Molecular Entity and Type 4 - New Combination

    11/15/23 9:53:06 AM ET
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PEV
    $PHGE
    $POAI
    $POCI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Rodman David Malcom exercised 2,171 shares at a strike of $16.00 and sold $65,586 worth of shares (2,171 units at $30.21) (SEC Form 4)

    4 - Mineralys Therapeutics, Inc. (0001933414) (Issuer)

    2/11/26 6:58:56 PM ET
    $MLYS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman and CEO Piluso Charles M. was granted 160,600 shares, increasing direct ownership by 180% to 250,032 units (SEC Form 4)

    4 - Data Storage Corp (0001419951) (Issuer)

    2/11/26 4:58:42 PM ET
    $DTST
    EDP Services
    Technology

    Chief Executive Officer O'Dowd William Iv bought $4,920 worth of shares (3,000 units at $1.64), increasing direct ownership by 0.69% to 434,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/11/26 4:38:15 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $PEV
    $PHGE
    $POAI
    $POCI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    RADNOR, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that on February 9, 2026, the Compensation Committee of Mineralys' Board of Directors granted inducement stock option awards covering 33,504 shares and inducement restricted stock unit awards covering 25,128 shares of Mineralys common stock to two new non-executive employees. The awards were granted under Mineralys' 2025 Employment Inducemen

    2/11/26 7:00:40 PM ET
    $MLYS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TPG and Jackson Financial Inc. Announce Launch of Long-Term Strategic Partnership

    Leverages the Power of TPG and Jackson's Complementary Capabilities, Strengthens Both Firms, and Unlocks Additional Avenues for Growth Over Time TPG Inc. (NASDAQ:TPG), a leading global alternative asset management firm, today announced the closing of the previously announced long-term strategic investment management partnership with Jackson Financial Inc. (NYSE:JXN) (Jackson®), a leading U.S. retirement services firm. Under the agreement, which was first announced by TPG and Jackson on January 6, 2026, TPG will manage a minimum commitment of $12 billion of AUM for Jackson, with economic incentives aligned to a long-term target of $20 billion. The non-exclusive investment management arra

    2/11/26 4:15:00 PM ET
    $JXN
    $TPG
    Life Insurance
    Finance
    Investment Managers

    First American Financial Reports Results for the Fourth Quarter and Full Year of 2025

    First American Financial Corporation (NYSE:FAF), a premier provider of title, settlement and risk solutions for real estate transactions and the leader in the digital transformation of its industry, today announced financial results for the fourth quarter and year ended Dec. 31, 2025. Current Quarter Highlights Earnings per diluted share of $2.05, or $1.99 per share on an adjusted basis Net investment gains of $15 million, or 11 cents per diluted share Purchase-related intangible amortization of $7 million, or 5 cents per diluted share Total revenue of $2.0 billion, up 22 percent compared with last year Adjusted total revenue of $2.0 billion, up 15 percent compared with la

    2/11/26 4:15:00 PM ET
    $FAF
    Specialty Insurers
    Finance

    $PEV
    $PHGE
    $POAI
    $POCI
    Leadership Updates

    Live Leadership Updates

    View All

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Coro Appoints Eyal Hen as Chief Financial Officer

    Veteran public-company finance leader joins Coro to support global scale and the company's next phase of growth Coro, the leading cybersecurity platform for Lean IT-driven organizations, today announced the appointment of Eyal Hen as its new Chief Financial Officer, effective immediately. Hen will oversee Coro's global finance organization as the company accelerates international growth and continues building the financial foundation to support its next stage of scale. "As Coro grows globally, we're deliberately investing in leadership that brings exactly what we need right now: public-company financial discipline combined with operational experience scaling global teams," said Joe Syko

    1/21/26 9:00:00 AM ET
    $REKR
    Telecommunications Equipment
    Telecommunications

    $PEV
    $PHGE
    $POAI
    $POCI
    Financials

    Live finance-specific insights

    View All

    First American Financial Reports Results for the Fourth Quarter and Full Year of 2025

    First American Financial Corporation (NYSE:FAF), a premier provider of title, settlement and risk solutions for real estate transactions and the leader in the digital transformation of its industry, today announced financial results for the fourth quarter and year ended Dec. 31, 2025. Current Quarter Highlights Earnings per diluted share of $2.05, or $1.99 per share on an adjusted basis Net investment gains of $15 million, or 11 cents per diluted share Purchase-related intangible amortization of $7 million, or 5 cents per diluted share Total revenue of $2.0 billion, up 22 percent compared with last year Adjusted total revenue of $2.0 billion, up 15 percent compared with la

    2/11/26 4:15:00 PM ET
    $FAF
    Specialty Insurers
    Finance

    Tower Semiconductor Reports Record Revenue for the Fourth Quarter of 2025

    MIGDAL HAEMEK, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Tower Semiconductor (NASDAQ/TASE: TSEM) reports today its results for the fourth quarter of 2025 and for the year ended December 31, 2025. Fourth Quarter of 2025 Results OverviewRecord revenue for the fourth quarter of 2025 was $440 million, representing revenue growth of 14% year-over-year and 11% quarter-over-quarter. The Company met its expressed revenue target of sequential quarter-over-quarter revenue growth within 2025 and an acceleration in the second half of the year, resulting in 23% growth fourth quarter over first quarter. Gross profit and operating profit for the fourth quarter of 2025 were $118 million

    2/11/26 7:00:00 AM ET
    $TSEM
    Semiconductors
    Technology

    Fortuna to release fourth quarter and full year 2025 financial results on February 18, 2026; Conference call at 12 p.m. Eastern time on February 19, 2026

    VANCOUVER, British Columbia, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE:FSM, TSX:FVI) announces that it will release its financial statements and MD&A for the fourth quarter and full year 2025 on Wednesday, February 18, 2026, after market close. A conference call to discuss the financial and operational results will be held on Thursday, February 19, 2026, at 9:00 a.m. Pacific time | 12:00 p.m. Eastern time. Hosting the call will be Jorge A. Ganoza, President and CEO, Luis D. Ganoza, Chief Financial Officer, David Whittle, Chief Operating Officer - West Africa, and Cesar Velasco, Chief Operating Officer - Latin America. Shareholders, analysts, media and interested invest

    2/11/26 5:00:00 AM ET
    $FSM
    Precious Metals
    Basic Materials

    $PEV
    $PHGE
    $POAI
    $POCI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by P10 Inc.

    SC 13D/A - P10, Inc. (0001841968) (Subject)

    12/13/24 9:00:20 PM ET
    $PX
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Exagen Inc.

    SC 13G/A - EXAGEN INC. (0001274737) (Subject)

    12/12/24 5:00:54 PM ET
    $XGN
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Lucid Diagnostics Inc.

    SC 13D/A - Lucid Diagnostics Inc. (0001799011) (Subject)

    12/12/24 4:30:32 PM ET
    $LUCD
    Medical/Dental Instruments
    Health Care